![]() |
市场调查报告书
商品编码
1954605
全球临床围产期软体市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)Clinical Perinatal Software Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025年全球临床围产期软体市场规模为3.7573亿美元,预计将从2026年的4.062亿美元成长到2034年的9.893亿美元,预测期内年复合成长率高达11.77%。北美将在2025年以41.32%的市场占有率引领市场,这主要得益于数位医疗的日益普及和人们对孕产妇健康的日益关注。
市场概览
临床围产期软体是指用于孕产妇、胎儿和新生儿照护的专用数位平台。这些系统透过即时监测、临床决策支援以及与电子健康记录(EHR)的整合,为医疗保健专业人员提供妊娠管理、分娩和新生儿护理方面的支援。人们越来越重视降低与分娩相关的风险、改善孕产妇结局以及医院系统的数位化,这些因素都显着推动了市场成长。
General Electric Company、Koninklijke Philips N.V.、PeriGen, Inc.、Clinical Computer Systems, Inc.等领导企业正透过创新产品和全球部署策略巩固其市场地位。
市场驱动因素
日益严重的孕产妇和新生儿健康风险
全球孕产妇和新生儿併发症负担日益加重是市场成长的主要驱动因素。子痫前症、产后出血、产程停滞、产程缺氧和早产相关併发症等情况需要持续监测和早期介入。
根据世界卫生组织2025年 4月发布的报告,2023年约有 26万名妇女死于妊娠和分娩相关原因,其中约 90%的死亡病例发生在低收入和中等收入国家。临床围产期软体透过实现早期检测、即时胎儿监测和改善临床决策,在降低死亡率方面发挥着非常重要的作用。
市场限制因子
新兴经济体采用率的延迟限制了整体市场扩张。基础设施差异、软体实施成本高昂、训练有素的人员短缺以及对捐助方资助计画的依赖阻碍了广泛部署。例如,尚比亚的电子围产期记录系统(ZEPRS)是在国际资助机构的支持下实施的,这凸显了其对外部资金的高度依赖。
IT 基础设施和整合的高昂初始成本进一步延缓了小型医院和专科诊所采用该系统。2024年,英国卫生和社会事务部和英格兰国民医疗服务体系(NHS England)每年投资 2.25亿美元用于加强产科和新生儿护理,这表明需要投入大量资金。
市场机会
与远距医疗和远距监测的整合
结合线上和线下咨询的混合式产前护理模式逐步普及,这带来了巨大的商机。新冠疫情期间,远距医疗的普及率激增。根据美国国家生物技术资讯中心(NCBI)于2023年 6月发布的一项研究,截至2020年 11月,17.3%的参与者接受远距产前护理,与2020年之前的1%相比,这一比例显着成长。
基于云端的SaaS 平台、行动应用程式和连网监测设备扩大孕产妇保健服务的覆盖范围,同时为医疗服务提供者创造基于订阅的收入模式。
市场趋势
迁移到云端和 SaaS 应用程式
由于成本效益、可扩展性和远端存取性,医院加速向云端系统迁移。儘管本地部署系统仍占据主导地位,但云端解决方案迅速发展,尤其是在高收入国家。
依类型
受无缝资料整合和工作流程效率的需求驱动,整合系统在2026年占据市场主导地位,市场占有率达69.18%。整合系统消除了资料孤岛,有助于提高临床决策的准确性。
依部署方式
由于医院优先考虑资料安全和合规性,本地部署系统在2026年占据了73.25%的市场占有率。然而,预计到2034年,基于云端的细分市场将以 13.93%的年复合成长率成长。
依应用领域划分
胎儿监护领域占据领先地位,2025年市场占有率为 37.4%,2026年市场占有率为 36.74%,这主要归功于其在检测异常心率模式和预防新生儿併发症方面的临床重要性。预计在预测期内,孕产妇健康管理产业将以 12.52%的年复合成长率成长。
依最终使用者划分
医院和诊所作为管理高风险妊娠和新生儿重症监护病例的机构,在2025年占据 69.7%的市场占有率,在2026年占据 69.49%的市场占有率。预计到2034年,专科诊所将以 12.44%的年复合成长率成长。
2025年,北美市场规模将达到 1.5525亿美元,到2026年将成长至 1.6817亿美元,继续保持其在该地区的领先地位。预计到2026年,光是美国市场规模就将达到1.5442亿美元,主要得益于孕产妇死亡率的上升(2022年为每10万活产22.3例死亡)。
2025年,欧洲市场规模达到9,280万美元,年复合成长率为9.96%。德国预计到2026年将达到2,394万美元,英国和法国也呈现稳定成长。
亚太地区市场规模在2025年达到8,500万美元,其中中国和印度预计在2026年将分别达到2,376万美元和1,838万美元。
拉丁美洲地区在2025年达到2,440万美元,而中东和非洲GCC地区在2025年达到760万美元。
The global clinical perinatal software market was valued at USD 375.73 million in 2025 and is projected to grow from USD 406.2 million in 2026 to USD 989.3 million by 2034, registering a strong CAGR of 11.77% during the forecast period. North America dominated the market in 2025 with a 41.32% share, driven by high digital health adoption and rising maternal health concerns.
Market Overview
Clinical perinatal software refers to specialized digital platforms used in maternal-fetal and neonatal care. These systems support healthcare providers in managing pregnancy, labor & delivery, and newborn care through real-time monitoring, clinical decision support, and integration with electronic health records (EHRs). The growing emphasis on reducing birth-related risks, improving maternal outcomes, and digitizing hospital systems is significantly contributing to market growth.
Leading players such as General Electric Company, Koninklijke Philips N.V., PeriGen, Inc., and Clinical Computer Systems, Inc. are strengthening their positions through innovative product launches and global expansion strategies.
Market Drivers
Rising Maternal & Neonatal Health Burden
The increasing global burden of maternal and neonatal complications is a primary driver of market growth. Conditions such as preeclampsia, hemorrhage, obstructed labor, intrapartum hypoxia, and prematurity-related complications require continuous monitoring and early intervention.
According to a WHO report published in April 2025, approximately 260,000 women died from pregnancy and childbirth-related causes in 2023, with nearly 90% occurring in low- and middle-income countries. Clinical perinatal software plays a crucial role in reducing mortality by enabling early detection, real-time fetal monitoring, and improved clinical decision-making.
Market Restraints
Limited adoption in emerging economies restricts overall market expansion. Infrastructure gaps, high software implementation costs, lack of trained personnel, and reliance on donor-funded programs hinder widespread deployment. For instance, Zambia's Electronic Perinatal Record System (ZEPRS) was implemented with support from global funding organizations, highlighting dependency on external financial assistance.
High upfront costs for IT infrastructure and integration further slow adoption among smaller hospitals and specialty clinics. In 2024, the Department of Health and Social Care and NHS England invested USD 225 million annually to enhance maternity and neonatal care, demonstrating the significant financial commitment required.
Market Opportunities
Integration with Telehealth & Remote Monitoring
The growing shift toward hybrid prenatal care models combining digital consultations with in-person visits presents a lucrative opportunity. Telehealth adoption surged during the COVID-19 pandemic. A study published by NCBI in June 2023 revealed that 17.3% of participants had telehealth prenatal visits in November 2020, compared to just 1% before 2020.
Cloud-based SaaS platforms, mobile apps, and connected monitoring devices are expanding access to maternal care while creating subscription-based revenue models for providers.
Market Trends
Shift Toward Cloud & SaaS Deployment
Hospitals are increasingly migrating toward cloud-based systems due to cost efficiency, scalability, and remote accessibility. Although on-premise systems currently dominate, cloud-based solutions are gaining traction, especially in high-income countries.
By Type
The integrated segment led the market with a 69.18% share in 2026, driven by demand for seamless data integration and improved workflow efficiency. Integrated systems reduce data silos and enhance clinical decision-making.
By Deployment
The on-premise segment accounted for 73.25% share in 2026, as hospitals prioritize data security and regulatory compliance. However, the cloud-based segment is projected to grow at a CAGR of 13.93% through 2034.
By Application
The fetal monitoring segment dominated with 37.4% share in 2025 and 36.74% in 2026, due to its clinical importance in detecting abnormal heart rate patterns and preventing neonatal complications. The maternal health management segment is projected to grow at 12.52% CAGR during the forecast period.
By End-User
Hospitals & clinics held 69.7% share in 2025 and 69.49% in 2026, as these settings manage high-risk pregnancies and neonatal intensive care cases. Specialty clinics are expected to grow at a CAGR of 12.44% through 2034.
In 2025, North America generated USD 155.25 million, increasing to USD 168.17 million in 2026, maintaining regional leadership. The U.S. market alone is estimated at USD 154.42 million in 2026, supported by rising maternal mortality rates (22.3 deaths per 100,000 live births in 2022).
Europe is projected to reach USD 92.8 million in 2025, growing at a CAGR of 9.96%. Germany is expected to reach USD 23.94 million in 2026, while the U.K. and France show steady growth.
Asia Pacific is valued at USD 85.0 million in 2025, with China and India reaching USD 23.76 million and USD 18.38 million in 2026, respectively.
Latin America recorded USD 24.4 million in 2025, while GCC in the Middle East & Africa reached USD 7.6 million in 2025.
Competitive Landscape
The market is moderately fragmented with dominant players including:
Recent developments include OBIX's partnership with Dubai Health (January 2025) and BrightHeart's FDA clearance for AI fetal heart ultrasound software (November 2024).
Conclusion
The global clinical perinatal software market is poised for strong expansion, growing from USD 375.73 million in 2025 to USD 989.3 million by 2034. Rising maternal health challenges, increasing digital health adoption, and growing integration of telehealth and AI-driven monitoring systems are key growth drivers. While high implementation costs and limited adoption in emerging economies present challenges, expanding cloud-based solutions and government investments are expected to sustain long-term growth across global healthcare systems.
Segmentation By Type
By Deployment
By Application
By End User
By Geography